Apr 14, 2026

Featuring perspectives from Dr Virginia F Borges and Dr Ian E Krop, including the following topics:

• Introduction: Biology of “Triple-Positive” Breast Cancer; Implications for Therapeutic Development (0:00)
• Cases from the GMO Survey (13:01)
• First-Line Therapy for Metastatic HER2-Positive Disease (20:01)
• Maintenance...

Apr 13, 2026

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics:

• Adjuvant treatment planning for Stage II or III microsatellite instability-high colon cancer (0:00)
• Roles of circulating tumor DNA (ctDNA), POLE mutations and advanced age in...

Apr 11, 2026

Featuring perspectives from Dr Paul G Richardson, including the following topics:

• EXCALIBER-RRMM: A Phase III trial of iberdomide, daratumumab and dexamethasone for relapsed/refractory multiple myeloma (0:00)
  • Lonial S et al. EXCALIBER-RRMM: A phase III trial of iberdomide, daratumumab, and dexamethasone...

Apr 8, 2026

Featuring perspectives from Dr Haley Ellis, Prof Eric Van Cutsem and Dr Zev Wainberg, moderated by Dr Lionel A Kankeu Fonkoua, including the following topics:

• Gastroesophageal cancer (0:00)
• Recurrent colorectal cancer (5:43)
• Colorectal cancer with brain metastases (9:59)

CME information and select...

Apr 7, 2026

Featuring an interview with Dr Ravin Ratan, including the following topics:

• Case: A woman in her early 40s who develops intense nausea and vomiting and is diagnosed with a pelvic desmoid tumor elects surveillance and experiences spontaneous regression of the tumor (0:00)
• Case: A woman in her late 30s with a painful...